We investigated the idea that the barrier is formed by normal myoepithelial cells (as opposed to transdifferentiated tumor cells) by staining for HER2 protein, HER2 mRNA and the myoepithelial protein, KRT14. The gene discussed is ERBB2; the disease is neoplasm.